0000000000808077

AUTHOR

Scott E. Binns

showing 2 related works from this author

The Effects of Sympathetic Inhibition on Metabolic and Cardiopulmonary Responses to Exercise in Hypoxic Conditions.

2015

Objective Pre-exertion skeletal muscle glycogen content is an important physiological determinant of endurance exercise performance: low glycogen stores contribute to premature fatigue. In low-oxygen environments (hypoxia), the important contribution of carbohydrates to endurance performance is further enhanced as glucose and glycogen dependence is increased; however, the insulin sensitivity of healthy adult humans is decreased. In light of this insulin resistance, maintaining skeletal muscle glycogen in hypoxia becomes difficult, and subsequent endurance performance is impaired. Sympathetic inhibition promotes insulin sensitivity in hypoxia but may impair hypoxic exercise performance, in p…

AdultMalemedicine.medical_specialtySympathetic nervous systemCardiac outputBlood PressureClonidinechemistry.chemical_compoundInsulin resistanceEndurance trainingHeart RateInternal medicinemedicineHumansHypoxiaExerciseGlycogenbusiness.industryPublic Health Environmental and Occupational HealthVO2 maxSkeletal muscleHypoxia (medical)medicine.diseaseEndocrinologymedicine.anatomical_structurechemistryOxyhemoglobinsEmergency MedicineExercise TestPhysical EnduranceSympatholyticsmedicine.symptombusinessWildernessenvironmental medicine
researchProduct

Methazolamide Plus Aminophylline Abrogates Hypoxia-Mediated Endurance Exercise Impairment.

2015

In hypoxia, endurance exercise performance is diminished; pharmacotherapy may abrogate this performance deficit. Based on positive outcomes in preclinical trials, we hypothesized that oral administration of methazolamide, a carbonic anhydrase inhibitor, aminophylline, a nonselective adenosine receptor antagonist and phosphodiesterase inhibitor, and/or methazolamide combined with aminophylline would attenuate hypoxia-mediated decrements in endurance exercise performance in humans. Fifteen healthy males (26 ± 5 years, body-mass index: 24.9 ± 1.6 kg/m(2); mean ± SD) were randomly assigned to one of four treatments: placebo (n = 9), methazolamide (250 mg; n = 10), aminophylline (400 mg; n = 9),…

AdultMalePhysiologymedicine.drug_classMethazolamideAdenosine receptor antagonistPlaceboYoung AdultEndurance trainingmedicineHumansCarbonic anhydrase inhibitorPhosphodiesterase inhibitorMethazolamideHypoxiaExercisebusiness.industryAltitudePublic Health Environmental and Occupational HealthGeneral MedicineHypoxia (medical)AminophyllineHealthy VolunteersAnesthesiaExercise TestPhysical EnduranceAminophyllineDrug Therapy Combinationmedicine.symptombusinessmedicine.drugHigh altitude medicinebiology
researchProduct